Chemoinformaics analysis of 1-Homoisoacevaltrate
| Molecular Weight | 494.537 | nRot | 10 |
| Heavy Atom Molecular Weight | 460.265 | nRig | 17 |
| Exact Molecular Weight | 494.215 | nRing | 3 |
| Solubility: LogS | -3.533 | nHRing | 2 |
| Solubility: LogP | 2.713 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 69 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 35 | No. of Aromatic Carbocycles | 0 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 25 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 0 |
| nHA | 10 | APOL | 72.441 |
| nHD | 0 | BPOL | 47.997 |
| QED | 0.254 |
| Synth | 5.404 |
| Natural Product Likeliness | 2.438 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.999 |
| Pgp-sub | 0.001 |
| HIA | 0.008 |
| CACO-2 | -4.731 |
| MDCK | 0.0000831 |
| BBB | 0.84 |
| PPB | 0.469534 |
| VDSS | 1.328 |
| FU | 0.421879 |
| CYP1A2-inh | 0.028 |
| CYP1A2-sub | 0.037 |
| CYP2c19-inh | 0.025 |
| CYP2c19-sub | 0.12 |
| CYP2c9-inh | 0.098 |
| CYP2c9-sub | 0.024 |
| CYP2d6-inh | 0.269 |
| CYP2d6-sub | 0.057 |
| CYP3a4-inh | 0.486 |
| CYP3a4-sub | 0.347 |
| CL | 4.172 |
| T12 | 0.222 |
| hERG | 0.189 |
| Ames | 0.985 |
| ROA | 0.638 |
| SkinSen | 0.277 |
| Carcinogencity | 0.926 |
| EI | 0.009 |
| Respiratory | 0.617 |
| NR-Aromatase | 0.006 |
| Antiviral | Yes |
| Prediction | 0.921079 |